Paratek Pharmaceuticals Inc expected to post a loss of 33 cents a share - Earnings Preview

Paratek Pharmaceuticals

28/04/2023 12:10

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 2 (estimated). 
    * The Boston Massachusetts-based  company is expected to
report  a
35.9% increase in revenue to $33.775 million from $24.86 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Paratek
Pharmaceuticals
Inc is for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $10​, above​ its last closing price
of $1.52. ​​​

This summary was machine generated April 28 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated